Back

Clinical and methodological considerations when interpreting meta-analyses of beta-blocker use in patients with chronic obstructive pulmonary disease

European Heart Journal

5 May 2021
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY BASIC SCIENCE Pharmacology and Pharmacotherapy

Contributors

Claudia Gulea
Claudia Gulea

Author

Jennifer K. Quint
Jennifer K. Quint

Author

Rosita Zakeri
Rosita Zakeri

Author

King's College London London , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Presentation
Beta-blockers in patients with heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: cardiovascular and respiratory outcomes
19 May 2025
thumbnail
Congress Presentation
Effectiveness of bisoprolol versus selective beta-1 blockers in the management of hypertension: a systematic review and meta-analysis of randomized cross-over trials
27 August 2021
thumbnail
Congress Presentation
Speckle tracking echocardiographic abnormalities in chronic obstructive pulmonary disease: insights from a systematic review and meta-analysis
13 December 2024
thumbnail
Congress Presentation
The need and duration of BB therapy in post MI patients with preserved left ventricular ejection fraction: a meta-analysis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources